Matthew W. Foehr, Director: Viking Therapeutics VKTX Planned sale · Filed 01/02

Trade details

Type: Planned sale notice
Stock: Viking Therapeutics VKTX
Person: Matthew W. FoehrDirector
Planned sale date: 26/01/02
Filed: 26/01/02

$561.7K to be sold

Viking Therapeutics trades, last 26 weeks

What else happened in Viking Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/03~02/01

Matthew W. Foehr's recent trades

Matthew W. FoehrPresident and CEO
SellOmniAb
Sell
OmniAb
OABI
$28.7K
19,244 sh
$28.7K
Filed 04/07
Traded 04/07
Matthew W. FoehrPresident and CEO
Planned saleOmniAb
Planned sale
OmniAb
OABI
$28.6K
19,244 sh
$28.6K
Filed 04/07
Traded 04/07
Matthew W. FoehrPresident and CEO
SellOmniAb
Sell
OmniAb
OABI
$52.7K
30,843 sh
$52.7K
Filed 02/18
Traded 02/18
Matthew W. FoehrPresident and CEO
SellOmniAb
Sell
OmniAb
OABI
$35.3K
20,754 sh
$35.3K
Filed 02/17
Traded 02/17
Matthew W. FoehrPresident and CEO
Planned saleOmniAb
Planned sale
OmniAb
OABI
$51.8K
30,451 sh
$51.8K
Filed 02/17
Traded 02/18